Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

Synthesis of [18F]FAZA using micro-fluidic technology

Vincent Bouvet, Melinda Wuest, Leonard Wiebe and Frank Wuest
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1449;
Vincent Bouvet
1Oncologic Imaging, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melinda Wuest
1Oncologic Imaging, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Wiebe
1Oncologic Imaging, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Wuest
1Oncologic Imaging, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1449

Objectives [18F]FAZA is a frequently used radiotracer for PET imaging of hypoxia. Current automated synthesis of [18F]FAZA involves a 5 min [18F]fluoride incorporation on 1-(2,3-di-O-acetyl-5-O-tosyl-a-D-arabinofuranosyl)-2-nitroimidazole followed by a 2 min hydrolysis step. However, the overall radiochemical yield (RCY) is reported to be low. Microfluidic technology is a rapidly evolving novel technique enabling micro-scale chemical reactions. This technology allows fast reactions in a simple experimental set-up, while using only very low amounts of starting material. The present study describes radiosynthesis of [18F]FAZA by means of micro-fluidic technology.

Methods Radiosynthesis in a microfluidic apparatus was optimized through varying various reaction parameters like temperature (80°C to 140°C), flow rate (8 uL x min-1 to 40 uL x min-1), reaction time (using different length of reactor), solvent (DMSO or CH3CN), and precursor concentration (2.5 mg x mL-1 to 5 mg x mL-1).

Results Optimal reaction conditions for [18F]fluoride incorporation were developed for small scale (0.1 MBq to 100 MBq) and large scale preparations (400 Mq to 2 GBq). Best reaction conditions at small scale include a reaction temperature of 120°C, a flow rate of 18 uL x min-1 for 5 min 20 sec, DMSO as solvent, and a precursor concentration of 2.5 mg x mL-1. These conditions afforded purified [18F]FAZA in 72% RCY. Large scale synthesis of [18F]FAZA employed a reaction temperature of 120°C, a flow rate of 28 uL x min-1 for 4 min 10 sec, DMSO as the solvent, and a precursor concentration of 5 mg x mL-1. These conditions gave HPLC-purified [18F]FAZA in 29 % RCY. Subsequent radiopharmacological evaluation of [18F]FAZA involved dynamic small animal PET studies in EMT-6 tumor bearing mice.

Conclusions Application of microfluidic technology significantly improved radiochemical yields of [18F]FAZA. Microfluidic technology represents an interesting alternative for the synthesis of clinically relevant PET radiotracers like [18F]FAZA. Future work is focused on the use of larger starting activities of [18F]fluoride (>5 GBq)

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis of [18F]FAZA using micro-fluidic technology
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis of [18F]FAZA using micro-fluidic technology
Vincent Bouvet, Melinda Wuest, Leonard Wiebe, Frank Wuest
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1449;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis of [18F]FAZA using micro-fluidic technology
Vincent Bouvet, Melinda Wuest, Leonard Wiebe, Frank Wuest
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1449;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

  • Effect of simvastatin on burn induced changes in tissue specific glucose metabolism
  • Bis(thiosemicarbazones) as bifunctional chelators for the room-temperature 64-copper labeling of peptides and proteins
  • Building local dynamic capabilities through SNM's annual meetings: A case study of the R&D of INER’s 68Ga generator and its related radiopharmaceutical synthesizer
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

New Radiopharmaceuticals-Broader/General Applications Posters

  • Effect of simvastatin on burn induced changes in tissue specific glucose metabolism
  • Bis(thiosemicarbazones) as bifunctional chelators for the room-temperature 64-copper labeling of peptides and proteins
  • Building local dynamic capabilities through SNM's annual meetings: A case study of the R&D of INER’s 68Ga generator and its related radiopharmaceutical synthesizer
Show more New Radiopharmaceuticals-Broader/General Applications Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire